SOPHiA GENETICS

Empowering a network of 770+ healthcare institutions worldwide and over 1.7 million genomic analyses to date, SOPHiA GENETICS is dedicated to patient care. Gilles MILLAT, Gilles, a hospital practitioner at Hospices Civils de Lyon - HCL, exemplifies our impact. Traditionally, analyzing Hereditary Cardiac Pathologies was time-consuming. But Dr. Millat has witnessed the transformative power of SOPHiA DDM™, our AI-powered, cloud-native platform. SOPHiA DDM™ streamlines workflows, leading to faster, more accurate analysis. 🤝 Dr. Millat's experience embodies our mission: empowering healthcare professionals globally with cutting-edge solutions. Learn about the SOPHiA DDM™ Platform: https://ter.li/n6kzkf #AIforHealthcare #SOPHiADDM #DataDrivenMedicine #PrecisionMedicine #CardiacDiagnostics

Is your #HRD analysis missing something? Try adding GIInger™. GIInger™ is a cutting-edge, deep learning algorithm that measures genomic instability in ovarian cancer samples using low-pass whole genome sequencing data. Designed to seamlessly integrate with different capture-based workflows, GIInger™ provides a universal approach to genomic instability measurement that complements your BRCA analysis for a complete HRD assessment. 🫚 Ready to add the missing spice to your workflow? Learn more: https://loom.ly/tFdfzzs #DataDrivenMedicine #PrecisionMedicine #CancerResearch #Innovation #Algorithm

🎬 Webinar alert! Don’t miss the online webinar with North Thames Genomics Laboratory Hub (NTGLH) to understand and discuss the recent changes in ovarian cancer HRD testing on 31 July 2024, 17:00 - 18:30 GMT. 💡 Why attend this webinar? • Testing Changes: Detailed explanation of the changes to HRD testing for advanced ovarian cancer. • Clinical Impact: Insights into what these changes mean for clinicians and their teams, with opportunities for questions and clarifications. • New Reporting System: Overview of the changes to the HRD report and scoring system, including template examples and where to find key information. • Validation and Confidence: Discussion on the validation, comparison of all 4 assays, and review of clinical data from SOPHiA GENETICS. Don’t miss this unique opportunity to engage in an open table discussion around all aspects of the new service, addressing specific requirements in HRD testing for ovarian cancer. 👉 Book your seat here: https://loom.ly/wa9sUv4 #Webinar #OvarianCancer #HRD #Cancer #Roundtable NHS North Thames Genomic Medicine Service

🚀 Exciting News: Dhiti Omics in India is now live on the SOPHiA DDM™ Platform. Dhiti Omics, a leader in precision molecular diagnostics, has implemented the SOPHiA DDM™ Platform to enhance its solid tumor testing and analytical capabilities. “Our team at Dhiti Omics is passionate about furthering the use of precision medicine and ensuring people in India and throughout the world have access to testing for better health outcomes,” said Sudha Rao, Ph.D, Founder and Director of Dhiti Omics Technologies. “By using SOPHiA DDM™, Dhiti Omics can ensure speed and accuracy of solid tumor testing to best support the Indian population,” mentioned Ricardo Ramos Mendonca Filho Ph.D., Managing Director, LAPAC, SOPHiA GENETICS. The combined efforts of Agilent Technologies and SOPHiA GENETICS make it possible for companies like Dhiti Omics to facilitate novel approaches to cancer research and diagnostics. 🔗 Read the full press release: https://loom.ly/tVqLGaI #DataDrivenMedicine #PrecisionMedicine #Oncology #PressRelease #Media

As the CEO of a global company with roots in the Basque Country, I’m proud to announce that SOPHiA GENETICS has become an official partner of Mondragon Goi Eskola Politeknikoa and ESTIA Institute of technology to support the future talents of this incredible region.   Having grown up in #BasqueCountry, this partnership is especially meaningful to me. It’s an honor to see SOPHiA GENETICS giving back to the community that shaped my journey.   A special thank you to Patxi Elissalde, Director of the ESTIA Campus, Emmanuel Alzuri, Mayor of Bidart, and Carlos García, General Manager of Mondragon University Faculty of Engineering, for joining us at today’s event in #Bidart.   Elkarrekin, osasunaren eta teknologiaren berrikuntzan hurrengo belaunaldia indartuko dugu. Aurrera eramango dugu berrikuntza!

Kaixo denoi! We are proud to announce that SOPHiA GENETICS, Mondragon Goi Eskola Politeknikoa, and ESTIA Institute of technology have become official partners to support the Basque talents of tomorrow. As a global company with roots in the Basque Country, SOPHiA GENETICS is particularly delighted to support the industry in this region and contribute to its growth and development. Mondragon Unibertsitatea, renowned for its innovative cooperative education model and strong industry ties, excels in combining academic excellence with real-world experience. Their dedication to applied research and development positions them as a leader in engineering education. The prestigious ESTIA Institute of Technology from #Bidart, France is celebrated for its cutting-edge research and strong connections with the technological sector. ESTIA's focus on innovation and collaboration aligns perfectly with our goals, making them a vital partner in this mission. 🎓 Our partnership will create enriching opportunities, including inspiring talks, hands-on internships, and collaborative projects, empowering young talents with the knowledge and skills to thrive in their careers. Together, let's drive healthcare innovation and educational excellence, ensuring a bright future for the Basque Country and beyond. #BasqueCountry #Education #Partnership #Media #Announcement #News

🌟 July is Sarcoma Awareness Month!     At SOPHiA GENETICS, we believe that collaboration between healthcare institutions is crucial in the fight against #cancer. By sharing data, insights, and expertise, we can accelerate research, improve diagnostics, and develop more effective treatments, together.    Imagine a global network of knowledge, where specific cases can be compared to countless others, leading to a faster diagnosis and a more effective treatment plan. The future is within reach through collaborative efforts that leverage the power of data-driven medicine.    This is why we want to know your opinion. 👉 Cast your vote and share your thoughts on the significance of collaboration in the fight against sarcoma.    #SarcomaAwarenessMonth #DataDrivenMedicine #PrecisionMedicine #Community

🚀 Our first Liquid Biopsy Community Forum was a success, bringing together 80+ experts from all over the world to share insights and build connections. This one hour virtual event included presentations from early access users, who shared their experience in internalizing MSK-ACCESS® powered with SOPHiA DDM™. The experience motivated us to continue to build and strengthen this amazing community. 🧬Are you interested in learning more about MSK-ACCESS® powered with SOPHiA DDM™? Visit our dedicated page: https://loom.ly/f7BbQJo #LiquidBiopsy #Community #DataDrivenMedicine #PrecisionOncology

Congratulations to Prof. Lars Steinmetz. one of the co-founders of SOPHiA GENETICS, for his appointment as chair of the department of genetics at #Stanford! #Genetics #Announcement

We're excited to have welcomed 35+ talented #interns and apprentices to our team in 2024! Being a SOPHiAN means being part of a community where innovation in #AI in healthcare thrives alongside team bowling nights like the one recently enjoyed by our interns from Switzerland. At SOPHiA GENETICS, we are dedicated to shaping the future by investing in the professional growth of tomorrow’s talents, with a strong emphasis on our core expertise: Data Science and Tech. Join our team and make a meaningful impact while having fun along the way. 👉 Check out our internship offers: https://loom.ly/PpyyEWI #Internship #DataScience #Tech #FutureTalents Pierre Gabioud | Inês Nunes Aguas | Lorena Egger | Arnau Llobet Rosell | Aikaterini Vitsaxaki | Rodrigo Oliveira